verified SJR 0,503 · Q3 • database Scopus / SJR & Web of Science indexed

Switzerland · S. Karger AG

workspace_premium Q3 — Medicine (miscellaneous) lock Subscription

Acta Haematologica

Acta Haematologica is a journal indexed in SJR in Medicine (miscellaneous) and Hematology with an H index of 65. It has an SJR impact factor of 0,503 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,503.

Acta Haematologica focuses its scope in these topics and keywords: chronic, aplastic, leukaemia, apparent, clinical, subsequent, cyclophosphamide, cryopreservation, infectionmarrow, retrospective, ...

ISSN: 0001-5792

Publisher: S. Karger AG

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,503 Q3

H-index 65

Acceptance rate pie_chart

29% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,503

H-index

Docs (year)

Docs 3y

279

Total refs

3456

Cites 3y

369

Citable 3y

257

Cites/Doc 2y

1.14

Ref/Doc

39.27

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Bone Marrow Histopathology Predicting Blast Crisis in Chronic Myeloid Leukemia

Vascular Endothelial Growth Factor and Thrombopoietin in Patients with Essential Thrombocythemia and Polycythemia vera and Thrombotic Complications

Diminished Release of Lactoferrin from Polymorphonuclear Leukocytes of Human Neonates

De novo CD5-Positive Diffuse Large B Cell Lymphoma Solely Presenting as Multiple Subcutaneous Nodules

Cytokines and Erythropoietin in the Blood of Patients with Erythroblastemia

Cytogenetic Studies in Chronic Myeloproliferative Disorders

Coexistence of Primary Refractory Anemia with Ringed Sideroblasts and T Cell-Lymphoblastic Non-Hodgkin Lymphoma

Coexistence of JAK2V617F Mutation and BCR-ABL1 Transcript in Two Chinese Patients with Chronic Myelogenous Leukemia

Clinical Significance of Simultaneous Determination of Serum Soluble Transferrin Receptor, Soluble Fas, Soluble Fas Ligand, Hepatocyte Growth Factor and Interleukin 18 Levels in a Patient with Hemophagocytic Syndrome

Cellular Engineering of HSV-tk Transduced, Expanded T Lymphocytes for Graft-versus-Host Disease Management

CD7+ and CD56+ Myeloid/Natural Killer Cell Precursor Acute Leukemia Treated with Idarubicin and Cytosine Arabinoside

CD5+ Immunophenotype in the Bone Marrow but Not in the Peripheral Blood in a Patient with Hairy Cell Leukemia

SHOW MORE ARTICLES

Cardiotoxicity and Cardioprotection in Childhood Cancer

Acute Intravascular Hemolysis due to ABO-Incompatible Platelet Transfusion

Bacteria in Blood Smears: Overwhelming Sepsis or Trivial Contamination

Autologous Hematopoietic Stem Cell Transplantation in Chronic Myeloid Leukemia with Different Clinical Stages

Autoimmune Thrombocytopenia and Neutropenia after Autologous Peripheral Blood Stem Cell Transplantation

Apoptosis Induced by Molecular Targeting Therapy in Hematological Malignancies

Aplastic Crisis Due to Human B19 Parvovirus Infection in Red Cell Pyrimidine-5' -Nucleotidase Deficiency

Alternative Concepts of Suicide Gene Therapy for Graft-versus-Host Disease after Adoptive Immunotherapy

ALK-Negative Anaplastic Large Cell Lymphoma and Hodgkin's Disease of Nodular Sclerosing Type in 2 Siblings

Age-Dependent Changes in the Incidence and Etiology of Childhood Thrombocytosis

Adoptive T-Cell Therapy for Epstein-Barr Virus-Positive Hodgkin's Disease

Adoptive Immunotherapy in Chimeras with Donor Lymphocytes

FAQs

Acta Haematologica has an SJR of 0,503 (best quartile Q3) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Acta Haematologica is 29%.

Acta Haematologica

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Acta Haematologica?

What is the APC / publication cost?

What is the acceptance rate?